Corporate Compass
Strategy, M&A and geopolitical pressures on global firms.
Energy Security Challenges Reshape Global Business and Investment Landscapes
Analyzing how the imperative for energy security is fundamentally restructuring international business strategies, investment flows, and supply chain resilience in the global economy.
FDA Policy Shifts Signal Strategic Pivot in Biopharma Development
An analysis of recent FDA guidance and regulatory actions indicating a strategic shift in how cell and gene therapies, particularly in vaccine and cancer treatments, are being fast-tracked globally.
Global Consumer Tech Demand to Reset in 2026 as Growth Shifts to Europe and MEA
NIQ and CTA project global consumer tech sales to remain flat in 2026, with regional shifts toward Europe and MEA and away from China, as AI and premiumization reshape demand.
How FDA’s Regulatory Flexibility Is Accelerating Global Cell and Gene Therapy Innovation
The US FDA is introducing new guidance that allows developers to leverage prior knowledge, reduce animal testing, and accelerate psychedelic therapies—reforms with significant implications for global biotech competition, investment flows, and cross-border regulatory alignment.
Lessons From Europe’s Loss of Biopharma Leadership, and Its Attempts to Recover
How Europe’s policy choices eroded its biopharma dominance, what that means for global drug innovation, and why the United States risks repeating the same mistakes.
Global Digital Compass Market Set to Double by 2035 as Autonomous Systems and IoT Drive Demand
The global digital compass market is projected to reach USD 6.35 billion by 2035, driven by connected devices and autonomous systems. Explore regional dynamics and global implications.